tribendimidine tribendimidine tribendimidine is a broad-spectrum anthelmintic agent developed in china, at the national institute of parasitic diseases in shanghai. it is a derivative of amidantel. tribendimidineclinical dataatc codenoneidentifiers iupac name n,n-bis(4-(1-dimethylamino)ethylideneaminophenyl)-1,4-phenylene dimethylidyneamine cas number115103-15-6 npubchem cid3086564chemspider2343161 yuniiyo6sod6ztjchemblchembl427256 ncomptox dashboard (epa)dtxsid50894077 chemical and physical dataformulac28h32n6molar mass452.606 g·mol−13d model (jsmol)interactive image smiles n(=c/c2ccc(\c=n\c1ccc(/n=c(/n(c)c)c)cc1)cc2)\c3ccc(\n=c(\n(c)c)c)cc3 inchi inchi=1s/c28h32n6/c1-21(33(3)4)31-27-15-11-25(12-16-27)29-19-23-7-9-24(10-8-23)20-30-26-13-17-28(18-14-26)32-22(2)34(5)6/h7-20h,1-6h3/b29-19+,30-20+,31-21+,32-22+ ykey:xoiogkhknqyulw-htnnxbmusa-n y ny (what is this?) (verify) in clinical trials, it was highly effective in treating ankylostomiasis, ascariasis and enterobiasis. it is also effective against clonorchiasis. however, animal studies suggest it is ineffective in treating schistosoma mansoni or fasciola hepatica disease. the drug has also performed well in trials against opisthorchiasis, curing about 70% of cases. tribendimidine is manufactured by shandong xinhua pharmaceutical company limited in zibo, shandong, china. it was approved by the china food and drug administration in 2007.